Clinical Trials Logo

68Ga-PSMA PET/CT Positive clinical trials

View clinical trials related to 68Ga-PSMA PET/CT Positive.

Filter by:
  • None
  • Page 1

NCT ID: NCT03454750 Recruiting - Clinical trials for Metastatic Castration Resistant Prostate Cancer

Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)

LU-PSMA
Start date: April 19, 2017
Phase: Phase 2
Study type: Interventional

Radiometabolic Therapy (RMT) with 177Lu PSMA 617 in advanced castration resistant prostate cancer (CRPC): efficacy and toxicity evaluation